Oramed Pharmaceuticals (ORMP) Net Cash Flow Growth (5y) (2015 - 2021)
Oramed Pharmaceuticals (ORMP) Net Cash Flow Growth (5y) (2015 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
| Date | Value |
|---|
| Nov 30, 2021 |
-94.80% |
| Aug 31, 2021 |
143.74% |
| May 31, 2021 |
221.26% |
| Feb 28, 2021 |
71.28% |
| Nov 30, 2020 |
-28.12% |
| May 31, 2020 |
4.35% |
| Feb 29, 2020 |
20.09% |
| Nov 30, 2019 |
-15.24% |
| Aug 31, 2019 |
2.30% |
| May 31, 2019 |
21.69% |
| Feb 28, 2019 |
50.51% |
| Nov 30, 2018 |
-4.52% |
| Aug 31, 2018 |
2.05% |
| May 31, 2018 |
19.14% |
| Feb 28, 2018 |
20.91% |
| Nov 30, 2017 |
-34.63% |
| Aug 31, 2017 |
55.16% |
| May 31, 2017 |
20.28% |
| Feb 28, 2017 |
-33.84% |
| Nov 30, 2016 |
-115.11% |
